LG Chem (051910) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
18 Jan, 2026Executive summary
Q3 2024 consolidated sales rose to KRW 12.67 trillion, with operating profit at KRW 498 billion and net income at KRW 1,013 billion, marking sequential improvement.
Profitability was driven by strong Energy Solution and stable Advanced Materials, while Petrochemicals, Life Sciences, and Farm Hannong faced margin pressures.
Sale of the polymer material business was completed, boosting non-operating income.
LG Chem ranked 4th globally in chemical firms by C&EN and 2nd in brand strength by Brand Finance.
Business performance varied by segment, with Energy Solution and Advanced Materials showing resilience, while Life Sciences and Farm Hannong faced profitability pressures.
Financial highlights
Gross margin improved to 18.1% in Q3 2024 from 15.3% in Q2 2024.
EBITDA margin rose to 13.0% in Q3 2024 from 12.7% in Q2 2024.
Cash and equivalents increased to KRW 8.8 trillion at quarter-end, up from KRW 7.2 trillion in Q2 2024.
Liabilities/equity ratio rose to 94.7% in Q3 2024 from 90.2% in Q2 2024.
Net debt/equity ratio increased to 42.3% in Q3 2024 from 39.7% in Q2 2024.
Outlook and guidance
CapEx for 2024 reduced from KRW 4 trillion to mid-KRW 2 trillion range due to market uncertainties.
Energy Solution expects continued volume growth despite inventory adjustments and lower metal prices, driven by EV and ESS demand.
Advanced Materials anticipates lower sales and profitability in the next quarter due to inventory adjustments and seasonality.
Petrochemicals profitability is expected to gradually improve as raw material prices fall and new capacity utilization increases.
Full-year cathode shipments expected to rise 25% YOY, but ASP to fall 40% YOY, weakening profitability.
Latest events from LG Chem
- Operating profit improved in Q2 2025, but sales fell and net income turned negative.051910
Q2 20253 Feb 2026 - 2025 closed with a net loss, but 2026 targets growth in high-value segments and restructuring.051910
Q4 20253 Feb 2026 - Q2 sales and profit rose sequentially, but net income and guidance declined on weak demand.051910
Q2 20243 Feb 2026 - 2024 profit fell sharply, but restructuring and high-value focus set stage for 2025 recovery.051910
Q4 20249 Jan 2026 - Profitability rebounded in Q1 2025 amid volatility, driven by cost controls and segment recovery.051910
Q1 20257 Jan 2026 - Profit rebounded in Q3 2025, led by cost cuts and one-time gains, but outlook stays cautious.051910
Q3 20252 Nov 2025